Home > Insider Trading > Filing (0001192482-13-000245)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1361248	Tetralogic Pharmaceuticals Corp	TLOG	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1590862	A. Peter Meyers	C/O Tetralogic Pharmaceuticals Corp 343 Phoenixville Pike Malvern PA 19355	Cfo & Treasurer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-12-17	142,857	$7.00	142,857	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Acquisiton	2013-12-17	164,394	$7.00	164,394	$7.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
487,888		2023-12-17	No	4	A	Direct

Footnotes

Twenty-five percent (25%) of the options or 41,098 options vested at the closing of the Company's initial public offering on 12/17/13; the balance of the options become exercisable at the rate of 3,424 options per month until all of the options are vested with 3,456 vested in the final month. Vesting ceases if the employee is no longer an active full-time employee of the Company on the vesting date. If there is a change of control as defined in the Company's 2013 Equity Plan, the entire unvested portion of the shares shall become immediately vested.